Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9335286 | Reproductive BioMedicine Online | 2005 | 4 Pages |
Abstract
This report presents the case of a 7-year-old girl with gonadotrophin-independent precocious puberty treated with cetrorelix [gonadotrophin-releasing hormone (GnRH) antagonist] after poor response to GnRH agonist therapy was observed in the endocrinology outpatient clinic. Uterine and ovarian morphology returned to within the normal prepubertal range after GnRH antagonist was injected subcutaneously. Vaginal bleeding stopped completely. The effects of GnRH antagonist treatment were comparable to those of GnRH agonist. The potential advantage of GnRH antagonists would be a clinically significant direct effect on the ovary, if it exists, and GnRH antagonists should be available for use in such children.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Meng-Hsing Wu, Shio-Jean Lin, Li-Hsiang Wu, Yueh-Chin Cheng, Yen-Yin Chou, Hsien-An Pan,